HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.

Abstract
Isoniazid (INH), a widely used drug in the prophylaxis and treatment of tuberculosis, is associated with a 1 to 2% risk of severe and potentially fatal hepatotoxicity. There is evidence that the INH metabolite hydrazine plays an important role in the mechanism of this toxicity. Metabolism of INH leads to the production of hydrazine via both direct and indirect pathways. In both cases, the activity of an INH amidase is required to hydrolyze an amide bond. In the present study, using a model of INH-induced hepatotoxicity in rabbits, pretreatment of rabbits with the amidase inhibitor bis-p-nitrophenyl phosphate 30 min before injection of INH inhibited the formation of INH-derived hydrazine and decreased measures of hepatocellular damage, hepatic triglyceride accumulation, and hypertriglyceridemia. Bis-p-nitrophenyl phosphate also potently inhibited the production of hydrazine from INH in in vitro microsomal incubations (IC50 2 microM). Although hepatic glutathione stores are decreased, they are not depleted in animals with INH-induced hepatotoxicity. Significant effects on hepatic microsomal cytochrome P-450 1A1/2 and cytochrome P-450 2E1 activities suggest that these isozymes may be involved in the mechanism of the toxicity. In conclusion, this study demonstrates the importance of amidase activity in this rabbit model of hepatotoxicity and provides additional evidence in support of the role of hydrazine in the mechanism of INH-induced hepatotoxicity.
AuthorsT C Sarich, S P Adams, G Petricca, J M Wright
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 289 Issue 2 Pg. 695-702 (May 1999) ISSN: 0022-3565 [Print] United States
PMID10215642 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antitubercular Agents
  • Cytochrome P-450 CYP2E1 Inhibitors
  • Enzyme Inhibitors
  • Hydrazines
  • Nitrophenols
  • Triglycerides
  • bis(4-nitrophenyl)phosphate
  • Amidohydrolases
  • amidase
  • Glutathione
  • Isoniazid
Topics
  • Amidohydrolases (antagonists & inhibitors)
  • Animals
  • Antitubercular Agents (metabolism, toxicity)
  • Chemical and Drug Induced Liver Injury (prevention & control)
  • Cytochrome P-450 CYP2E1 Inhibitors
  • Enzyme Inhibitors (pharmacology)
  • Glutathione (metabolism)
  • Hydrazines (metabolism, toxicity)
  • In Vitro Techniques
  • Isoniazid (metabolism, toxicity)
  • Male
  • Microsomes, Liver (drug effects, enzymology)
  • Nitrophenols (pharmacology)
  • Rabbits
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: